The efficacy and safety of abatacept or infliximab in ra patients with an inadequate response to MTX: Results from a 1-year double-blind, randomized, placebo-controlled trial

Category Primary study
JournalJournal of Rheumatology
Year 2007

This article is included in 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
  • ATTEST [Abatacept or infliximab vs placebo, a Trial for Tolerability, Efficacy and Safety in Treating rheumatoid arthritis] (7 documents)
This article is part of the following matrixes of evidence:
Loading references information
This article has no abstract
Epistemonikos ID: d2944a0711f380f22f358e2d155de57129fdbc57
First added on: Feb 03, 2013